which companies make glp-1 drugs The future of in healthcare: Vital's role in enhancing metabolic treatment programs Novo Nordisk was the first
Description
In contrast, a cheaper alternative to Ozempic, such as Metformin, costs only $10 to $30 per month
Long-term safety data in seniors is still limited
GLP-1 RAs in combination with metformin showed even more weight loss and improvement in markers of hyperandrogenism
2019;366:l4898
